Signal from the log
Robigo
Series A
Robigo développe des biologiques modifiés destinés à protéger les rendements agricoles. Leaps by Bayer mène le tour de série A. L'opération est un vrai tour de table, mais elle porte sur l'agriculture et non sur la santé, donc elle reste hors du fil de Bolus.
Spotted Amount read from the headline
Announced on , logged by the watch of 17 September 2026.
- Operation
- Funding round
- Stage
- Series A
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
Led by Leaps by Bayer
What is missing before publishing
- No public amount. A missing amount is never estimated or inferred from a filing.
Provenance
Source businesswire
Logged on 17 September 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification The fields shown come from an automatic reading of the source headline. They have not yet been checked against the press release and should not be quoted as verified.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.